(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.86%) $83.13
(-1.16%) $1.619
(-0.40%) $2 337.80
(-0.13%) $27.50
(0.64%) $928.00
(-0.17%) $0.933
(-0.12%) $11.01
(-0.24%) $0.798
(0.00%) $92.17
1.41% HKD 12.98
Live Chart Being Loaded With Signals
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China...
Stats | |
---|---|
Dagens volum | 3.52M |
Gjennomsnittsvolum | 2.01M |
Markedsverdi | 11.42B |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.114 ( 2020-09-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.32 |
ATR14 | HKD0.0360 (0.28%) |
Volum Korrelasjon
YiChang HEC ChangJiang Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
YiChang HEC ChangJiang Korrelasjon - Valuta/Råvare
YiChang HEC ChangJiang Økonomi
Annual | 2023 |
Omsetning: | HKD6.29B |
Bruttogevinst: | HKD4.99B (79.21 %) |
EPS: | HKD2.26 |
FY | 2023 |
Omsetning: | HKD6.29B |
Bruttogevinst: | HKD4.99B (79.21 %) |
EPS: | HKD2.26 |
FY | 2022 |
Omsetning: | HKD3.74B |
Bruttogevinst: | HKD2.85B (76.00 %) |
EPS: | HKD0.0871 |
FY | 2021 |
Omsetning: | HKD913.79M |
Bruttogevinst: | HKD483.70M (52.93 %) |
EPS: | HKD-0.667 |
Financial Reports:
No articles found.
YiChang HEC ChangJiang Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.0885 | 2016-06-08 |
Last Dividend | HKD0.114 | 2020-09-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 9 | -- |
Total Paid Out | HKD2.08 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.94 | -- |
Div. Sustainability Score | 8.02 | |
Div.Growth Potential Score | 4.29 | |
Div. Directional Score | 6.15 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
0168.HK | Ex Dividend Knight | 2023-06-21 | Annually | 0 | 0.00% | |
3737.HK | Ex Dividend Junior | 2023-10-17 | Annually | 0 | 0.00% | |
1668.HK | No Dividend Player | 2023-09-26 | Annually | 0 | 0.00% | |
0710.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
2230.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
1243.HK | Ex Dividend Junior | 2023-08-25 | Annually | 0 | 0.00% | |
0308.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% | |
3993.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
1800.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
0836.HK | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.317 | 1.500 | 3.67 | 5.50 | [0 - 0.5] |
returnOnAssetsTTM | 0.156 | 1.200 | 4.79 | 5.75 | [0 - 0.3] |
returnOnEquityTTM | 0.268 | 1.500 | 8.13 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.397 | 0.800 | 8.01 | 6.41 | [1 - 3] |
quickRatioTTM | 0.869 | 0.800 | 9.59 | 7.67 | [0.8 - 2.5] |
cashRatioTTM | 0.387 | 1.500 | 8.96 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.205 | -1.500 | 6.59 | -9.88 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.415 | 2.00 | 9.53 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.170 | 2.00 | 9.42 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.329 | -1.500 | 8.68 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.792 | 1.000 | 0.132 | 0.132 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.141 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.477 | 1.000 | 8.46 | 8.46 | [0.2 - 2] |
assetTurnoverTTM | 0.494 | 0.800 | -0.0406 | -0.0325 | [0.5 - 2] |
Total Score | 8.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 5.23 | 1.000 | 9.57 | 0 | [1 - 100] |
returnOnEquityTTM | 0.268 | 2.50 | 8.80 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.170 | 2.00 | 9.61 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.415 | 2.00 | 9.53 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0791 | 1.500 | -2.81 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.198 | 1.000 | 7.56 | 0 | [0.1 - 0.5] |
Total Score | 4.29 |
YiChang HEC ChangJiang
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.